<<< Back to main page
Associated Press
01.26.2005, 05:54 AM
German drug maker Bayer AG said Wednesday it has now settled more than
2,900 suits related to its cholesterol-lowering drug Lipobay, or Baycol,
paying more than US$1.1 billion in out-of-court deals.
Bayer pulled Lipobay, marketed as Baycol in the United States, in 2001
after it was linked to a rare muscle-wasting syndrome and about 100 patient
deaths.
In a regular posting to its Web site, the Leverkusen-based company said it
has now settled 2,933 cases and agreed to pay a total of US$1.113 billion
without admitting liability. Some 6,359 cases are still pending.
In November the company said it had reached settlements in 2,895 cases and
paid some US$1.1 billion in out-of-court deals.
Zeus Information Service
Alternative Views on Health
www.zeusinfoservice.com
All information, data and material contained, presented or
provided herein is for general information purposes only and
is not to be construed as reflecting the knowledge or opinion
of Zeus Information Service.
Subscribe Free/Unsubscribe: email
[email protected]
Feel free to forward far and wide!
